Cost-effectiveness and budget impact analysis of smoking cessation interventions in chronic obstructive pulmonary disease patients in Thailand

Smoking Cessation ◽

Cost Effectiveness ◽

Pulmonary Disease ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Chronic Obstructive ◽

PRS17 - BUDGET IMPACT ANALYSIS OF THE USE OF UMECLIDINIUM BROMIDE/VILANTEROL 62.5/25 MCG IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN SPAIN

Value in Health ◽

10.1016/j.jval.2018.09.2411 ◽

2018 ◽

Vol 21 ◽

pp. S406

Author(s):

L.A. Vallejo-Aparicio ◽

A. Huerta

Keyword(s):

Pulmonary Disease ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Chronic Obstructive ◽

BUDGET IMPACT ANALYSIS OF HOME ADVANCED NON-INVASIVE VENTILATION FOR SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Value in Health ◽

10.1016/j.jval.2016.03.690 ◽

2016 ◽

Vol 19 (3) ◽

pp. A299

Author(s):

S. Coughlin ◽

F.W. Peyerl ◽

S.H. Munson ◽

A.J. Ravindranath ◽

Jr. T.L. Lee-Chiong

Keyword(s):

Pulmonary Disease ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Chronic Obstructive ◽

Invasive Ventilation ◽

Non Invasive ◽

Non Invasive Ventilation

Budget Impact Analysis of Indacaterol/Glycopyrronium in the Treatment of Chronic Obstructive Pulmonary Disease (Copd) in Colombia

Value in Health ◽

10.1016/j.jval.2017.08.2662 ◽

2017 ◽

Vol 20 (9) ◽

pp. A888

Author(s):

A Patino ◽

E Karpf ◽

D Londoño

Keyword(s):

Pulmonary Disease ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Chronic Obstructive ◽

PRS13 A Budget Impact Analysis of Indacaterol for the Treatment of Chronic Obstructive Pulmonary Disease in Colombia

Value in Health ◽

10.1016/j.jval.2012.03.297 ◽

2012 ◽

Vol 15 (4) ◽

pp. A53

Author(s):

L.F. Giraldo ◽

J.G. Ariza ◽

T. Acosta ◽

J.F. Pinzon

Keyword(s):

Pulmonary Disease ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Chronic Obstructive ◽

Budget Impact Analysis of Aclidinium Bromide In The Treatment of Chronic Obstructive Pulmonary Disease

Value in Health ◽

10.1016/j.jval.2016.09.1180 ◽

2016 ◽

Vol 19 (7) ◽

pp. A550

Author(s):

R Yagudina ◽

A Kulikov ◽

E Makarova

Keyword(s):

Pulmonary Disease ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Chronic Obstructive ◽

Aclidinium Bromide

Simulation-Based Estimates of Effectiveness and Cost-Effectiveness of Smoking Cessation in Patients with Chronic Obstructive Pulmonary Disease

PLoS ONE ◽

10.1371/journal.pone.0024870 ◽

2011 ◽

Vol 6 (9) ◽

pp. e24870 ◽

Cited By ~ 28

Author(s):

Kokuvi Atsou ◽

Christos Chouaid ◽

Gilles Hejblum

Keyword(s):

Smoking Cessation ◽

Cost Effectiveness ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Simulation Based

A systematic review of quality and cost–effectiveness derived from Markov models evaluating smoking cessation interventions in patients with chronic obstructive pulmonary disease

Expert Review of Pharmacoeconomics & Outcomes Research ◽

10.1586/14737167.2015.1001976 ◽

2015 ◽

Vol 15 (2) ◽

pp. 301-316 ◽

Cited By ~ 9

Author(s):

Florian Kirsch

Keyword(s):

Systematic Review ◽

Smoking Cessation ◽

Cost Effectiveness ◽

Pulmonary Disease ◽

Markov Models ◽

Chronic Obstructive ◽

PRS12 Budget Impact Analysis of Tiotropium Bromide Versus Ipratropium Bromide on the Top of Standard Therapy in the Treatment of Chronic Obstructive Pulmonary Disease (Copd) in Russian Federation

Value in Health ◽

10.1016/j.jval.2012.03.296 ◽

2012 ◽

Vol 15 (4) ◽

pp. A53

Author(s):

A. Kulikov ◽

I. Komarov

Keyword(s):

Pulmonary Disease ◽

Russian Federation ◽

Standard Therapy ◽

Ipratropium Bromide ◽

Impact Analysis ◽

Budget Impact ◽

Tiotropium Bromide ◽

Chronic Obstructive ◽

The cost-effectiveness of antidepressants for smoking cessation in chronic obstructive pulmonary disease (COPD) patients

Addiction ◽

10.1111/j.1360-0443.2009.02723.x ◽

2009 ◽

Vol 104 (12) ◽

pp. 2110-2117 ◽

Cited By ~ 13

Author(s):

Constant P. Van Schayck ◽

Janneke Kaper ◽

Edwin J. Wagena ◽

Emiel F. M. Wouters ◽

Johannes L. Severens

Keyword(s):

Smoking Cessation ◽

Cost Effectiveness ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Copd Patients ◽

The Cost

PRS1 BUDGET IMPACT ANALYSIS OF UMECLIDINIUM VERSUS TIOTROPIUM IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) FROM THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM PERSPECTIVE

Value in Health Regional Issues ◽

10.1016/j.vhri.2019.08.424 ◽

2019 ◽

Vol 19 ◽

pp. S77

Author(s):

D. Silva ◽

L.T.M. Saturnino ◽

M.R. Gazzotti ◽

O.A. Nascimento ◽

R. Alfonso-Cristancho

Keyword(s):

Pulmonary Disease ◽

Healthcare System ◽

Impact Analysis ◽

Budget Impact ◽

Public Healthcare ◽

Chronic Obstructive ◽

System Perspective ◽

Healthcare System Perspective